Fig. 6.

Kaplan-Meier survival estimates to compare patients with de novo or asynchronous metastases that received surgery versus those that did not have this in their treatment plan. A.) Median overall survival for de novo, operative was 58.3 months, while median survival for de novo, non-operative was 59.9 months. Asynchronous metastases, operative was 114.2 months, while non-operative was 175.1 months. B.) Median BoM survival for de novo, operative was 58.3 months, while median survival for de novo, non-operative was 59.9 months. Asynchronous metastases, operative was 35.7 months, while non-operative was 56.9 months. OP = operative, NOOP = non-operative.